AZN
$68.27
Revenue | $12024Mn |
Net Profits | $960Mn |
Net Profit Margins | 7.98% |
Astrazeneca Plc’s revenue jumped 7.29% since last year same period to $12024Mn in the Q4 2023. On a quarterly growth basis, Astrazeneca Plc has generated 4.63% jump in its revenue since last 3-months.
Astrazeneca Plc’s net profit jumped 6.55% since last year same period to $960Mn in the Q4 2023. On a quarterly growth basis, Astrazeneca Plc has generated -30.13% fall in its net profits since last 3-months.
Astrazeneca Plc’s net profit margin fell -0.69% since last year same period to 7.98% in the Q4 2023. On a quarterly growth basis, Astrazeneca Plc has generated -33.22% fall in its net profit margins since last 3-months.
EPS Estimate Current Quarter | 0.97 |
EPS Estimate Current Year | 0.97 |
Astrazeneca Plc’s earning per share (EPS) estimates for the current quarter stand at 0.97 - a 22.68% jump from last quarter’s estimates.
Astrazeneca Plc’s earning per share (EPS) estimates for the current year stand at 0.97.
Earning Per Share (EPS) | 0 |
Dividend Per Share (DPS) | 0.99 |
Astrazeneca Plc’s earning per share (EPS) fell -100% since last year same period to 0 in the Q1 2024. This indicates that the Astrazeneca Plc has generated -100% annual rate of fall in its earning per share (EPS) in the last 4 quarters.
Astrazeneca Plc declared 0.99 dividend per share during the earnings announcement for Q1 2024.
Earnings Date | Estimated EPS | Reported EPS | Surprise % |
---|---|---|---|
2024-04-25 | 0.97 | 0 | -100% |